Gilead Sciences, Inc. (LON:0QYQ)
London · Delayed Price · Currency is GBP · Price in USD 116.73
-0.67 (-0.57%)
At close: Oct 9, 2025
Gilead Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Net Income | 6,311 | 480 | 5,613 | 4,566 | 6,201 | 89 | Upgrade |
Depreciation & Amortization | 2,770 | 2,767 | 2,693 | 2,103 | 2,050 | 1,480 | Upgrade |
Stock-Based Compensation | 872 | 835 | 766 | 637 | 635 | 643 | Upgrade |
Other Adjustments | -101 | 7,626 | 1,236 | 3,529 | 2,009 | 7,772 | Upgrade |
Change in Receivables | 21 | 139 | 157 | -406 | 313 | -1,171 | Upgrade |
Changes in Inventories | -709 | -426 | -842 | -310 | 11 | -195 | Upgrade |
Changes in Accounts Payable | 34 | 290 | -347 | 226 | -118 | 80 | Upgrade |
Changes in Accrued Expenses | 47 | 108 | 458 | -775 | 689 | 640 | Upgrade |
Changes in Income Taxes Payable | -1,205 | -732 | -1,768 | -364 | -361 | -778 | Upgrade |
Changes in Other Operating Activities | -110 | -259 | 39 | -134 | -45 | -214 | Upgrade |
Operating Cash Flow | 7,930 | 10,828 | 8,005 | 9,072 | 11,384 | 8,346 | Upgrade |
Operating Cash Flow Growth | 59.05% | 35.27% | -11.76% | -20.31% | 36.40% | -8.73% | Upgrade |
Capital Expenditures | -499 | -523 | -585 | -728 | -579 | -650 | Upgrade |
Purchases of Investments | -85 | -736 | -2,372 | -1,942 | -3,897 | -20,770 | Upgrade |
Proceeds from Sale of Investments | - | 2,592 | 1,844 | 2,002 | 2,910 | 32,718 | Upgrade |
Payments for Business Acquisitions | -939 | -4,840 | -1,152 | -1,797 | -1,584 | -25,920 | Upgrade |
Other Investing Activities | 33 | 58 | -1 | -1 | 19 | 7 | Upgrade |
Investing Cash Flow | -3,466 | -3,449 | -2,265 | -2,466 | -3,131 | -14,615 | Upgrade |
Long-Term Debt Issued | - | 3,464 | 1,980 | - | - | 8,184 | Upgrade |
Long-Term Debt Repaid | -1,890 | -1,970 | -2,250 | -1,500 | -4,750 | -2,500 | Upgrade |
Net Long-Term Debt Issued (Repaid) | -1,890 | 1,494 | -270 | -1,500 | -4,750 | 5,684 | Upgrade |
Issuance of Common Stock | 550 | 422 | 232 | 309 | 169 | 256 | Upgrade |
Repurchase of Common Stock | -1,907 | -1,150 | -1,000 | -1,396 | -546 | -1,583 | Upgrade |
Net Common Stock Issued (Repurchased) | -1,357 | -728 | -768 | -1,087 | -377 | -1,327 | Upgrade |
Common Dividends Paid | -3,960 | -3,918 | -3,809 | -3,709 | -3,605 | -3,449 | Upgrade |
Other Financing Activities | -369 | -281 | -279 | -173 | -145 | -138 | Upgrade |
Financing Cash Flow | -4,112 | -3,433 | -5,125 | -6,469 | -8,877 | 770 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 81 | -40 | 57 | -63 | -35 | 43 | Upgrade |
Net Cash Flow | 2,371 | 3,906 | 673 | 74 | -659 | -5,634 | Upgrade |
Beginning Cash & Cash Equivalents | 2,772 | 6,085 | 5,412 | 5,338 | 5,997 | 11,631 | Upgrade |
Ending Cash & Cash Equivalents | 5,144 | 9,991 | 6,085 | 5,412 | 5,338 | 5,997 | Upgrade |
Free Cash Flow | 7,431 | 10,305 | 7,420 | 8,344 | 10,805 | 7,696 | Upgrade |
Free Cash Flow Growth | -27.89% | 38.88% | -11.07% | -22.78% | 40.40% | -7.49% | Upgrade |
FCF Margin | 25.88% | 36.02% | 27.55% | 30.92% | 40.01% | 31.60% | Upgrade |
Free Cash Flow Per Share | 5.89 | 8.21 | 5.90 | 6.61 | 8.56 | 6.09 | Upgrade |
Levered Free Cash Flow | 4,749 | 3,199 | 5,043 | 3,110 | 3,122 | 6,170 | Upgrade |
Unlevered Free Cash Flow | 7,384 | 2,379 | 5,870 | 5,775 | 14,053 | 8,288 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.